Related Experiment Video
Updated: Jul 29, 2025

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
Prognostic Value of Tumor Multifocality in Pediatric Papillary Thyroid Carcinoma: A Real-Life Multicentric Study
Yangmengyuan Xu1, Lei Shi2, Jie Wu3
1Department of Nuclear Medicine, West China Hospital, Sichuan University, Chengdu, China.
Insights
Multifocal papillary thyroid cancer (PTC) in pediatric patients did not show an independent association with decreased disease-free survival (DFS) after comprehensive analysis. This finding suggests multifocality is not a significant predictor of poorer outcomes in this specific pediatric cohort.
Area of Science:
- Endocrinology
- Pediatric Oncology
- Surgical Oncology
Background:
- Papillary thyroid cancer (PTC) is the most common endocrine malignancy in children and adolescents.
- Tumor multifocality, the presence of multiple distinct tumor foci, is a recognized feature of PTC, but its prognostic significance in pediatric cases remains debated.
- Understanding factors influencing clinical outcomes is crucial for optimizing treatment strategies in pediatric PTC.
Purpose of the Study:
- To investigate the association between tumor multifocality and clinical outcomes, specifically disease-free survival (DFS), in pediatric patients with papillary thyroid cancer.
- To determine if tumor multifocality is an independent risk factor for persistent or recurrent disease in this population.
Main Methods:
- A multicenter retrospective study utilizing prospectively collected data from three tertiary hospitals in China.
- Inclusion criteria comprised patients aged 18 years or younger diagnosed with PTC who underwent total thyroidectomy and radioiodine ablation between 2005 and 2020.
- Disease-free survival (DFS) was defined as the absence of persistent or recurrent disease, with analysis conducted using Cox proportional hazards regression models.
Main Results:
- The study included 173 pediatric patients (median age 16 years), with multifocal disease identified in 34.1% (59 patients).
- After a median follow-up of 57 months, 36.4% (63 patients) experienced persistent disease.
- While univariable analysis showed a significant association between multifocality and decreased DFS (HR=1.90, p=0.01), this association lost statistical significance after multivariate adjustment (HR=1.20, p=0.55). Subgroup analysis of clinically M0 patients also yielded non-significant results.
Conclusions:
- In a highly selected cohort of pediatric patients with papillary thyroid cancer undergoing surgery, tumor multifocality was not found to be an independent risk factor for decreased disease-free survival.
- These findings suggest that multifocality alone may not significantly impact long-term outcomes in pediatric PTC when other clinical factors are considered.
Objective:
To investigate the association of multifocality with clinical outcomes in pediatric papillary thyroid cancer.
Study Design:
Multicenter retrospective study of prospectively collected data.
Setting:
Tertiary referral center.
Methods:
This study included patients 18 years or younger who underwent total thyroidectomy and radioiodine ablation for papillary thyroid carcinoma (PTC) between 2005 and 2020 at 3 tertiary adult and pediatric hospitals in China. For disease-free survival (DFS), events were defined as persistent and/or recurrent diseases. The primary outcome was the association of tumor multifocality and DFS, assessed using Cox proportional hazards regression models.
Results:
One hundred and seventy-three patients (median age 16 years [range, 5-18 years]) were recruited. Multifocal diseases were seen in 59 patients (34.1%). After a median follow-up of 57 (range, 12-193 months) months, 63 (36.4%) patients had persistent diseases. There was a significant association between tumor multifocality and decreased DFS on univariable analysis (hazard ratio [HR] = 1.90, p = .01), yet it was nonsignificant after multivariate adjustment (HR = 1.20, p = .55). In a subgroup analysis of 132 pediatric patients with clinically M0 PTC, neither unadjusted HR (2.21, p = .06) nor adjusted HR (1.70, p = .27) of multifocal PTC was significantly higher in comparison to unifocal PTC.
Conclusion:
In this highly selective surgical pediatric patient cohort with PTC, tumor multifocality was not an independent risk factor for decreased DFS.
More Related Videos
07:43Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples
Published on: July 29, 2017
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024